SPRB•benzinga•
RBC Capital Maintains Sector Perform on Spruce Biosciences, Lowers Price Target to $0.5
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 16, 2025 by benzinga